Fatigue News and Research

RSS

Study sheds light on the intricate relationship between depression and brain activity

A significant new study published in the Cyborg Bionic Systems journal by Fanli Kong and colleagues sheds light on the intricate relationship between depression and brain activity, particularly focusing on the basolateral amygdala (BLA) in rats.

26 Jun 2024

Extended-release ketamine tablets offer new hope for treatment-resistant depression

The BEDROC trial found that extended-release ketamine tablets (R-107) significantly improve depressive symptoms in treatment-resistant depression patients, with the 180 mg dose showing the most efficacy. The treatment was well-tolerated with minimal side effects.

26 Jun 2024

Therapists learn how to help farmers cope with stress before it’s too late

The farmers' co-op here is a center of hope every spring. It's where farmers buy seed and fertilizer for the summer's crops, and where they seek tips to maximize their harvest of corn and soybeans.

25 Jun 2024

UCL research reveals anxiety as a major risk factor for Parkinson's

The risk of developing Parkinson's is at least twice as high in people with anxiety compared to those without, finds a new study by UCL researchers.

24 Jun 2024

Pennington Biomedical researchers partner on award-winning long COVID study

Dr. John Kirwan, Executive Director of Pennington Biomedical Research Center, is serving as a co-principal investigator on the Pathobiology in RECOVER of Metabolic and Immune Systems, or PROMIS, study.

21 Jun 2024

Moderate exercise linked to reduced burnout and higher job satisfaction among employees

Employees who exercise moderately feel less emotionally exhausted and more personally satisfied at work than their less active co-workers, a new University of Michigan study found.

20 Jun 2024

UQ launches study on managing work-life balance and work stress recovery

University of Queensland researchers need participants for a study to help understand how people manage their work-life balance and recover from daily work stress.

16 Jun 2024

New therapeutic approach for Duchenne muscular dystrophy combines LED therapy with idebenone

In an animal model of Duchenne muscular dystrophy, Brazilian researchers tested a therapy that combines photobiomodulation using laser light or light-emitting diodes (LEDs) with idebenone, an antioxidant compound investigated for application in neurodegenerative diseases.

14 Jun 2024

EULAR endorses self-management of inflammatory arthritis with RECLARIT

EULAR - The European Alliance of Associations for Rheumatology - recommends patient self-management for people with inflammatory arthritis.

14 Jun 2024

Physical activity and cognitive training can improve mood for adults with Down's syndrome

A new study has discovered that physical activity and cognitive training can improve levels of life satisfaction and mood for adults with Down's syndrome.

13 Jun 2024

Instron® Launches Next Generation Autoinjector Testing System

...

From Instron - USA 12 Jun 2024

Natural antioxidants could delay age-related decline in male testosterone production

Natural polyphenolic compounds to enhance testosterone production and prevent age-related hypogonadism in aging males.

12 Jun 2024

Differing definitions of iron deficiency lead to divergent estimates of prevalence, study finds

How different ways of defining iron deficiency (ID) impact the prevalence estimates of this common disorder among women.

12 Jun 2024

Ashwagandha boosts memory and mood in clinical trial

A clinical trial found that acute and 30-day Ashwagandha supplementation improves cognitive function and mood markers, showing significant benefits in memory, attention, and well-being without adverse effects.

10 Jun 2024

Understanding Crohn's disease through 'mini-gut' models

Cambridge scientists have grown 'mini-guts' in the lab to help understand Crohn's disease, showing that 'switches' that modify DNA in gut cells play an important role in the disease and how it presents in patients.

10 Jun 2024

Stanford study finds 15-day paxlovid treatment safe but ineffective for long COVID

In a clinical trial conducted by Stanford Medicine investigators and their colleagues, a 15-day course of Paxlovid - an antiviral drug combination targeting SARS-CoV-2, the virus that causes COVID-19 - proved safe as an extended-duration treatment but didn't lessen select symptoms of the syndrome known as long COVID: the persistence, or reappearance, of COVID-related symptoms three months or more after an initial COVID-19 infection.

7 Jun 2024

New antioxidant biomaterial may provide relief to people living with chronic pancreatitis

Northwestern University researchers have developed a new antioxidant biomaterial that someday could provide much-needed relief to people living with chronic pancreatitis.

7 Jun 2024

Study offers insights into the use of muscle-building supplements among adolescents, young adults in Canada

A recent study from the University of Toronto has revealed critical insights into the use of muscle-building supplements (such as whey protein and creatine) among adolescents and young adults in Canada.

4 Jun 2024

IgG from long COVID patients induces specific symptoms in mice, confirming autoimmunity's role

Researchers found that IgG from long COVID patients induces specific symptoms in mice, suggesting IgG's role in long COVID pathogenesis.

3 Jun 2024

Headband meditation may offer pain relief and improved function after Cushing's surgery

Patients with Cushing's syndrome who are recovering from surgery and wear a headband that tracks brain activity while they meditate may have less pain and better physical functioning compared with patients not using the device, suggests a study being presented Monday at ENDO 2024, the Endocrine Society's annual meeting in Boston, Mass.